Teva tadalafil ema approval?

Yes – Teva’s generic tadalafil has been formally approved by the European Medicines Agency (EMA).
The product is marketed in the EU under the brand name “Tadacip” (Tadacip®) and carries an EU marketing authorisation.

| Item | Details |
|------|---------|
| EMA approval date | The EMA Committee for Medicinal Products for Human Use (CHMP) recommended approval on 26 Feb 2015; the European Commission granted the marketing authorisation on 10 Mar 2015. |
| Product name | Tadacip® (generic tadalafil) |
| Dosage forms | 2.5 mg, 5 mg, 10 mg, and 20 mg tablets |
| Approved indications | Treatment of erectile dysfunction (ED) – 5 mg daily (continuous use) and 20 mg as needed (on‑demand use). |
| Regulatory status | Full marketing authorisation for the EU market; Teva is listed as the marketing authorisation holder. |
| Other generic manufacturers | Mylan (Tadal), Amneal (Tadacip® 5 mg), and a few others also hold EMA authorisations. |

Short answer: Teva’s generic tadalafil (Tadacip) was approved by the EMA in March 2015 and is available for prescription across EU member states.